BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 30315345)

  • 1. Burden of illness of follicular lymphoma and marginal zone lymphoma.
    Monga N; Nastoupil L; Garside J; Quigley J; Hudson M; O'Donovan P; Parisi L; Tapprich C; Thieblemont C
    Ann Hematol; 2019 Jan; 98(1):175-183. PubMed ID: 30315345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating the Burden of Illness of Relapsed Follicular Lymphoma and Marginal Zone Lymphoma in Ontario, Canada.
    Kuruvilla J; Ewara EM; Elia-Pacitti J; Ng R; Eberg M; Kukaswadia A; Sharma A
    Curr Oncol; 2023 Apr; 30(5):4663-4676. PubMed ID: 37232810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reassessment of non-hodgkins's lymphoma with a "nodular" growth variant: a clinicopathologic study of follicular, mantle cell and marginal zone lymphomas prospectively diagnosed with multiparameter analyses.
    Kadowaki I; Ichinohasama R; Sasaki O; Kimura J; Kameoka JI; Meguro K; Endo K; Tobinai K; Sasaki T; Sawai T; Ooya K
    Leuk Lymphoma; 1998 Oct; 31(3-4):393-403. PubMed ID: 9869204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic Reviews.
    Monga N; Garside J; Gurung B; Quigley J; O'Donovan P; Tapprich C; Nastoupil L; Thieblemont C; Loefgren C
    Pharmacoecon Open; 2020 Dec; 4(4):575-591. PubMed ID: 32200522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Lymphoma.
    Alhaj Moustafa M; Peterson J; Hoppe BS; Jiang J; Wiseman GA; Witzig TE; Tun HW
    Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):618-625. PubMed ID: 35400611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marginal zone B-cell lymphoma: a retrospective immunophenotypic analysis.
    Kost CB; Holden JT; Mann KP
    Cytometry B Clin Cytom; 2008 Sep; 74(5):282-6. PubMed ID: 18500740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.
    Metcalf RA; Monabati A; Vyas M; Roncador G; Gualco G; Bacchi CE; Younes SF; Natkunam Y; Freud AG
    Hum Pathol; 2014 Aug; 45(8):1730-6. PubMed ID: 24925224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transformation of marginal zone lymphoma (and association with other lymphomas).
    Casulo C; Friedberg J
    Best Pract Res Clin Haematol; 2017; 30(1-2):131-138. PubMed ID: 28288708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare lymphomas in routine practice - Treatment and outcome in marginal zone lymphoma in the prospective German Tumour Registry Lymphatic Neoplasms.
    Knauf W; Abenhardt W; Koenigsmann M; Maintz C; Sandner R; Zahn MO; Schnell R; Tech S; Kaiser-Osterhues A; Houet L; Marschner N;
    Hematol Oncol; 2021 Aug; 39(3):313-325. PubMed ID: 33942348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patients.
    Heilgeist A; McClanahan F; Ho AD; Witzens-Harig M
    Cancer; 2013 Jan; 119(1):99-106. PubMed ID: 22736411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive retrospective cohort study of the journey of B-cell lymphoma in Taiwan.
    Pei SN; Wang MC; Ma MC; Kuo CY; Liao CK; Qiu H; Rothwell LA; Liu Y
    Sci Rep; 2021 May; 11(1):10069. PubMed ID: 33980914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
    Nathwani BN; Anderson JR; Armitage JO; Cavalli F; Diebold J; Drachenberg MR; Harris NL; MacLennan KA; Müller-Hermelink HK; Ullrich FA; Weisenburger DD
    J Clin Oncol; 1999 Aug; 17(8):2486-92. PubMed ID: 10561313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of rheumatological disorders on lymphomas and myeloma: a report on risk and survival from the UK's population-based Haematological Malignancy Research Network.
    Kane E; Painter D; Smith A; Crouch S; Oliver S; Patmore R; Roman E
    Cancer Epidemiol; 2019 Apr; 59():236-243. PubMed ID: 30844679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas.
    Alhaj Moustafa M; Borah BJ; Moriarty JP; Dholakia R; Jiang L; Li K; Witzig TE; Hoppe BS; Peterson J; Cerhan JR; Tun HW
    Clin Lymphoma Myeloma Leuk; 2023 Apr; 23(4):259-265. PubMed ID: 36775698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine indolent nodular lymphoma.
    Valli VE; Vernau W; de Lorimier LP; Graham PS; Moore PF
    Vet Pathol; 2006 May; 43(3):241-56. PubMed ID: 16672571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marginal Zone Lymphoma: State-of-the-Art Treatment.
    Sindel A; Al-Juhaishi T; Yazbeck V
    Curr Treat Options Oncol; 2019 Dec; 20(12):90. PubMed ID: 31807935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular lymphoma and marginal zone lymphoma: how many diseases?
    Laurent C; Cook JR; Yoshino T; Quintanilla-Martinez L; Jaffe ES
    Virchows Arch; 2023 Jan; 482(1):149-162. PubMed ID: 36394631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoarchitectural patterns of germinal center antigens including LMO2 assist in the differential diagnosis of marginal zone lymphoma vs follicular lymphoma.
    Dyhdalo KS; Lanigan C; Tubbs RR; Cook JR
    Am J Clin Pathol; 2013 Aug; 140(2):149-54. PubMed ID: 23897248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of first-line treatment for follicular lymphoma based on outcomes and medical economics.
    Muneishi M; Nakamura A; Tachibana K; Suemitsu J; Hasebe S; Takeuchi K; Yakushijin Y
    Int J Clin Oncol; 2018 Apr; 23(2):375-381. PubMed ID: 29063983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An open-label phase 2 trial of entospletinib in indolent non-Hodgkin lymphoma and mantle cell lymphoma.
    Andorsky DJ; Kolibaba KS; Assouline S; Forero-Torres A; Jones V; Klein LM; Patel-Donnelly D; Smith M; Ye W; Shi W; Yasenchak CA; Sharman JP
    Br J Haematol; 2019 Jan; 184(2):215-222. PubMed ID: 30183069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.